Life Science REIT's portfolio valuation dropped by 7.1% in the year ended 31 December 2023 as market movements in offices pulled values down.
The group’s portfolio is now valued at £382.3m, with its labs assets proving more resilient. Space defined
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.
